BioWorld

Dec. 29, 2003

View Archived Issues

Scientists Demonstrate For First Time How Human Immune System, Lipid Metabolism, Merge In Body

Read More

SMIP Technology Powering Trubion Through Early Years

Read More

U.S. Patent Disclosures

Read More

Other News To Note

Read More

Aventis Pasteur Files For Approval Of Long-Acting Meningitis Vaccine

Aventis Pasteur filed a biologics license application for Menactra, a conjugate vaccine believed to provide protection against meningococcal meningitis for a longer period than the company's currently marketed product. (BioWorld Today) Read More

Peninsula Launches Phase III With Lead Product Doripenem

Read More